Navigation Links
Upsher-Smith To Present New Research On USL255 (Extended-Release Topiramate) At 2013 American Epilepsy Society Annual Meeting
Date:11/18/2013

earch/mode/display/st/usl255/sy/2013/sb/All/id/1729022">Impact of Delayed-Dose Administration of USL255, an Extended-Release Topiramate Formulation  
Poster 2.157; Sunday, December 8, 2013; 8 a.m. – 5 p.m. EST;  
Authors Present 12 p.m. – 2 p.m.

Abstracts of the poster presentations can be found online at www.aesnet.org.  To schedule an interview with an investigator, please contact Elizabeth Likly at elikly@klcpr.com.  

About Upsher-Smith's Phase 3 (PREVAIL) Clinical Trial

The PREVAIL trial was a randomized, multicenter, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of USL255 as adjunctive therapy in patients with refractory POS. 

PREVAIL was conducted under a Special Protocol Assessment (SPA) agreement with the FDA.  More information about the trial is available at www.clinicaltrials.gov (NCT01142193).

An open-label extension study to evaluate the safety of USL255 as adjunctive therapy in patients with refractory POS who had participated in PREVAIL is ongoing.  The open-label extension study can be found by searching NCT01191086 on www.clinicaltrials.gov.

Upsher-Smith's Epilepsy Pipeline

Upsher-Smith's clinical development pipeline includes three investigational drugs that are being studied for the management of seizure disorders.  USL255 is an investigational once-daily, extended-release topiramate for the management
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
2. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
3. Upsher-Smith Is Honored with Prestigious Industry Award for Excellence and Innovation
4. Upsher-Smith Teams Up With Epilepsy Foundation of Minnesota for 2012 Stroll for Epilepsy
5. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
6. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
7. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
8. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
9. Upsher-Smith Introduces Newly Redesigned Corporate Website
10. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
11. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014  The BioFusionary Corporation, Inc. (TBC), ... proprietary electromagnetic induction platform with aesthetic and surgical ... under which TBC will merge with ... an all-stock transaction. Upon completion of ... the Australian Stock Exchange under the code COT. ...
(Date:7/29/2014)... 29, 2014 Today, Frost & Sullivan ... Sullivan Best Practices Award for Customer Value Leadership. ... platform that connects digital health application developers, medical ... pharmaceutical companies, prevention and wellness companies, population health ... Each year, Frost & Sullivan presents this award ...
(Date:7/29/2014)... --  Health 2.0 announces Bernard Tyson , CEO ... Eric Topol , Patrick Soon-Shiong , and Samsung,s President ... Annual Fall Conference this coming Sept. 21-24 in ... is set to host the very first Wearable Tech Fashion ... Consumer Tech & Wearables: Powering Healthy Lifestyles. The panel ...
Breaking Medicine Technology:The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 2Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 4Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3
(Date:7/29/2014)... CRN International has promoted a longtime executive ... Upton, an 11-year veteran at the radio marketing company, ... managing the day-to-day execution of all CRN client campaigns. ... all activities for CRN clients, which include some ... The department interfaces directly with clients, sets project timelines ...
(Date:7/29/2014)... Somerset, NJ (PRWEB) July 29, 2014 ... drug development solutions and advanced delivery technologies for ... that Dr. Jeff Browne, R&D Director and US ... the Bioavailability of Absorption-Limited Drugs with Lipid-Based Formulations ... 30th Annual Meeting of the Japan Society of ...
(Date:7/29/2014)... 2014 TMG Health, the leading ... health plans in the Medicare Advantage, Medicare Part ... held its annual Client Forum at its National ... theme, “Partners in Excellence: Navigating the Post-Reform Landscape ... leaders from TMG Health’s Client base of Health ...
(Date:7/29/2014)... According to an article in the Daily ... a 52 year old woman in India. The surgery took ... had no idea that she had such a large tumor ... for years, but did not connect it to a possible ... the massive uterine fibroid after Latha was admitted for heavy ...
(Date:7/29/2014)... 2014 “Our years of experience ... fail to insulate their homes properly simply due ... preventing heat transfer and conduction,” Clean Crawls says ... recently released an article explaining exactly how ... energy bills. , To contact Clean Crawls for ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Director to Lead Client Services Department 2Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 3Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3Health News:What’s The Point of Insulation? Clean Crawls Explains The Dangers of Heat Transfer in Recently Released Article 2
... some common symptoms, due to which physicians often tend to ... occurs when the tongue or throat muscles // relax too ... more than 50 times an hour during sleep, causing snoring ... seconds. The problem is twice as common in men, and ...
... who survive Hodgkin's disease are found to have a higher ... that is given for the same, a new research has ... lymph nodes and the other immune system organs. Researchers found ... breast cancer if they survived Hodgkin's lymphoma. Dr Lois B. ...
... National Hospital, Oslo and other collaborating Universities from many ... 20 years in 900 adults has found that // ... risk of oral cancer in smoking individuals by at ... of developing cardiovascular deaths, the study has found that ...
... worldwide are estimated to suffer from multiple sclerosis (MS), ... young adults, and has a significant impact on the ... an average reduction in relapse rates of 30% in ... to weekly., ,Data from the extension of a ...
... been a dream come true for the scientists who been ... Administration is expected to take an extra step ahead as ... cloned animals, as well as their offspring, are safe to ... to cloning techniques, with Canadian Scientists having proved themselves following ...
... answer for the prayers of millions of men suffering ... robotic arms promises sooner recovery, less pain, scarring and ... cancer is the second leading cause of death among ... Asian men. It is estimated that one in six ...
Cached Medicine News:Health News:Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea 2Health News:NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks 2Health News:New Hope For Patients With Relapsing Multiple Sclerosis 2Health News:Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer 2
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip, 0.6 mm dual sideports, 20 gauge....
Nucleus chopper. For bimanual nucleus division....
Medicine Products: